Augurex Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $5M

  • Investors
  • 4

Augurex General Information

Description

Developer of biomarkers designed to transform patient clinical management for improved disease outcomes. The company's bio-marker blood tests are based on point-of-care proprietary blood testing that connects with disease-specific applications and electronic health records, enabling doctors to optimize patient management by personalizing clinical decision-making.

Contact Information

Website
www.augurex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Outcome Management (Healthcare)
Biotechnology
Corporate Office
  • 887 Great Northern Way
  • Suite 220
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Augurex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 14-Mar-2024 $5M 00000 Completed Generating Revenue
6. Later Stage VC 25-Jan-2017 00000 Completed Generating Revenue
5. Angel (individual) 01-Feb-2011 000.00 00000 Completed Startup
4. Angel (individual) 01-May-2009 000.00 000.00 Completed Startup
3. Angel (individual) 01-Nov-2007 000.00 000.00 Completed Startup
2. Grant 01-Jan-2007 $52.8K Completed Startup
1. Spin-Off 01-Jan-2007 Completed Startup
To view Augurex’s complete valuation and funding history, request access »

Augurex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomarkers designed to transform patient clinical management for improved disease outcomes. The company's b
Diagnostic Equipment
Vancouver, Canada
17 As of 2024
00000
000000000000 00000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
0000000000000
Boston, MA
000 As of 0000
00000
00000000000 00000

0000 0

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
000000000 00000 (000
Burlingame, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Augurex Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Emulate Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
Halo Labs Venture Capital-Backed Burlingame, CA 00 000.00 00000000000 000.00
BioTissue (Biotechnology) Venture Capital-Backed Miami, FL 000 00000 0000000000 0 00000
Clearside Biomedical Formerly VC-backed Alpharetta, GA 00 00000 00000000 00000
Adverum Biotechnologies Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
To view Augurex’s complete competitors history, request access »

Augurex Executive Team (3)

Name Title Board Seat Contact Info
Norma Biln Co-Founder, Chief Executive Officer & Board Member
Natalie Dakers Chairman & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Augurex Board Members (6)

Name Representing Role Since
David Demers Self Board Member 000 0000
Doug Buchanan Self Board Member 000 0000
Natalie Dakers Self Chairman & Board Member 000 0000
Norma Biln Augurex Co-Founder, Chief Executive Officer & Board Member 000 0000
Paul Terry Ph.D Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Augurex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Augurex Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Government of Canada Government 000 0000 000000 0
Genome British Columbia Not-For-Profit Venture Capital Minority 000 0000 000000 0
WUTIF Capital Angel Group Minority 000 0000 000000 0
New Ventures BC Accelerator/Incubator 000 0000 000000 0
To view Augurex’s complete investors history, request access »

Augurex FAQs

  • When was Augurex founded?

    Augurex was founded in 2007.

  • Who is the founder of Augurex?

    Norma Biln and Anthony Marotta Ph.D are the founders of Augurex.

  • Who is the CEO of Augurex?

    Norma Biln is the CEO of Augurex.

  • Where is Augurex headquartered?

    Augurex is headquartered in Vancouver, Canada.

  • What is the size of Augurex?

    Augurex has 17 total employees.

  • What industry is Augurex in?

    Augurex’s primary industry is Diagnostic Equipment.

  • Is Augurex a private or public company?

    Augurex is a Private company.

  • What is Augurex’s current revenue?

    The current revenue for Augurex is 00000.

  • How much funding has Augurex raised over time?

    Augurex has raised $122K.

  • Who are Augurex’s investors?

    Government of Canada, Genome British Columbia, WUTIF Capital, and New Ventures BC have invested in Augurex.

  • Who are Augurex’s competitors?

    Emulate, Halo Labs, BioTissue (Biotechnology), Clearside Biomedical, and Adverum Biotechnologies are some of the 6 competitors of Augurex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »